Out of the job description for our strategy and corporate chief officer, applications close this Sunday.
Our ideal candidate will be responsible for directing and coordinating the company's long and short term strategies, research and development and marketing activities with an overall goal of maximising investment.
Responsible for overseeing business strategies to support PYC’s current pre clinical drug development programs and additional pipeline programs in 2022 ultimately into commercialisation. Expand our market capitalisation by working with investors, other Biotechnology and Pharmaceutical companies to expand the market capitalisation of PYC
It is pretty much spelled out what to expect for the company following the tox data update.
Perth based development and reasearch base needs to match up management capacity to engage with future partners and developers, expanded pipeline workload and coordination.
all IMO
- Forums
- ASX - By Stock
- PYC
- Ann: Retina Target Engagement Confirmed in Large Eye
PYC
pyc therapeutics limited
Add to My Watchlist
4.91%
!
$1.26

Ann: Retina Target Engagement Confirmed in Large Eye, page-76
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.26 |
Change
-0.065(4.91%) |
Mkt cap ! $734.9M |
Open | High | Low | Value | Volume |
$1.30 | $1.32 | $1.24 | $3.898M | 3.092M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 31074 | $1.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 4016 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 31074 | 1.260 |
1 | 10000 | 1.250 |
3 | 6727 | 1.240 |
1 | 40000 | 1.220 |
1 | 2470 | 1.210 |
Price($) | Vol. | No. |
---|---|---|
1.295 | 4016 | 1 |
1.300 | 12521 | 1 |
1.330 | 756 | 1 |
1.370 | 10000 | 1 |
1.395 | 7168 | 1 |
Last trade - 16.10pm 11/08/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online